Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Pharmacia & Upjohn and Chiron establish HCV collaboration

Feb. 4, 1998

Prokinetic motilin agonists in development at Ohmeda

Jan. 30, 1998

Meiji Seika describes 5-HT3 partial agonists for GI disorders

Jan. 29, 1998

Vion prepares more active prodrug of beta-L-FD4C

Jan. 27, 1998

Randomized trial compares interferon alfa-2b + ribavirin to interferon alone for HCV

Jan. 26, 1998

Anti-H. pylori agents from Pfizer

Jan. 23, 1998

Pivotal Zadaxin trial to begin in Japan

Jan. 22, 1998

Combination HCV therapy receives priority classification from FDA

Jan. 21, 1998

Interim Maxamine phase I data reported

Jan. 19, 1998

Vertex researchers report 3-D structure of hepatitis C enzyme

Jan. 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...